Mads Thomassen

11.6k total citations
179 papers, 3.3k citations indexed

About

Mads Thomassen is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Mads Thomassen has authored 179 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 52 papers in Cancer Research and 47 papers in Genetics. Recurrent topics in Mads Thomassen's work include Cancer Genomics and Diagnostics (40 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and BRCA gene mutations in cancer (20 papers). Mads Thomassen is often cited by papers focused on Cancer Genomics and Diagnostics (40 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers) and BRCA gene mutations in cancer (20 papers). Mads Thomassen collaborates with scholars based in Denmark, United States and Germany. Mads Thomassen's co-authors include Torben A. Kruse, Qihua Tan, Martin J. Larsen, Mark Burton, Vibe Skov, Hans Carl Hasselbalch, Martin Bak, Thomas Stauffer Larsen, Anne‐Marie Gerdes and Ole Weis Bjerrum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mads Thomassen

172 papers receiving 3.2k citations

Peers

Mads Thomassen
Tracy Chaplin United Kingdom
Malek Faham United States
Meena Gujrati United States
Stephen Meek United Kingdom
Ignacio Varela Spain
Alan H. Shih United States
Ellen van Drunen Netherlands
Per Henrik Lindblom Sweden
Bernd Hinzmann Germany
A. Robert MacLeod United States
Tracy Chaplin United Kingdom
Mads Thomassen
Citations per year, relative to Mads Thomassen Mads Thomassen (= 1×) peers Tracy Chaplin

Countries citing papers authored by Mads Thomassen

Since Specialization
Citations

This map shows the geographic impact of Mads Thomassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads Thomassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads Thomassen more than expected).

Fields of papers citing papers by Mads Thomassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads Thomassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads Thomassen. The network helps show where Mads Thomassen may publish in the future.

Co-authorship network of co-authors of Mads Thomassen

This figure shows the co-authorship network connecting the top 25 collaborators of Mads Thomassen. A scholar is included among the top collaborators of Mads Thomassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads Thomassen. Mads Thomassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomassen, Mads, et al.. (2025). Can Donor Hearts Survive 24 Hours of Hypothermic Oxygenated Machine Perfusion Before Transplantation?. The Journal of Heart and Lung Transplantation. 44(4). S34–S35.
2.
Steffensen, Lasse Bach, Martin Bjerregård Pedersen, Martin J. Larsen, et al.. (2025). Mutational landscape of atherosclerotic plaques reveals large clonal cell populations. JCI Insight. 10(10). 3 indexed citations
3.
Jensen, Maj‐Britt, Bent Ejlertsen, Mads Thomassen, et al.. (2025). Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000. Acta Oncologica. 64. 147–155. 1 indexed citations
4.
Thomassen, Mads, et al.. (2025). Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy. International Journal of Molecular Sciences. 26(2). 515–515. 7 indexed citations
5.
Jensen, Maj‐Britt, Bent Ejlertsen, Mads Thomassen, et al.. (2025). Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study. Breast Cancer Research and Treatment. 212(2). 309–323.
6.
Cédile, Oriane, Mads Thomassen, Michael Møller, et al.. (2025). Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue. International Journal of Laboratory Hematology. 47(4). 669–679. 1 indexed citations
7.
Hasselbalch, Hans Carl, Vibe Skov, Lasse Kjær, et al.. (2024). The CHIP-clinic as the catalyst of preventive medicine. SHILAP Revista de lepidopterología. 3. 1 indexed citations
8.
Cédile, Oriane, Jakub Krejcik, Niels Abildgaard, et al.. (2024). Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 25(23). 12569–12569.
9.
Elkjaer, Maria L., Mhaned Oubounyt, Lars Vitved, et al.. (2024). Single-Cell Multi-Omics Map of Cell Type–Specific Mechanistic Drivers of Multiple Sclerosis Lesions. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200213–e200213. 10 indexed citations
10.
Burton, Mark, et al.. (2024). GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma. Scientific Reports. 14(1). 17639–17639. 4 indexed citations
11.
12.
Lee, Soojung, Marco Mele, Tonje Johansen, et al.. (2023). Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer. Breast Cancer Research. 25(1). 46–46. 24 indexed citations
13.
Sørensen, Mia Dahl, Mark Burton, Mads Thomassen, et al.. (2022). Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas. Brain Pathology. 33(1). e13111–e13111. 12 indexed citations
14.
Hviid, Thomas Vauvert F., Jens Ole Eriksen, Bent Ejlertsen, et al.. (2021). Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British Journal of Cancer. 125(10). 1388–1398. 11 indexed citations
15.
Frisch, Tobias, Maria L. Elkjaer, Richard Reynolds, et al.. (2020). Multiple Sclerosis Atlas: A Molecular Map of Brain Lesion Stages in Progressive Multiple Sclerosis. SHILAP Revista de lepidopterología. 3(1). 122–129. 17 indexed citations
16.
Burton, Mark, Mads Thomassen, F. Alan Andersen, et al.. (2017). The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges. Experimental Dermatology. 26(10). 926–933. 5 indexed citations
17.
Rathe, Mathias, Mads Thomassen, René Liang Shen, et al.. (2016). Chemotherapy Modulates Intestinal Immune Gene Expression Including Surfactant Protein-D and Deleted in Malignant Brain Tumors 1 in Piglets. Chemotherapy. 61(4). 204–216. 8 indexed citations
18.
Skov, Vibe, Mark Burton, Mads Thomassen, et al.. (2015). Supervised multi-classifier separation of the ph-negative myeloproliferative neoplasms. Haematologica. 100. 1 indexed citations
19.
Tan, Qihua, Mette Nyegaard, Klaus Brusgaard, et al.. (2007). Arrayed Primer Extension in the “Array of Arrays” Format: A Rational Approach for Microarray-Based SNP Genotyping. Genetic Testing. 11(2). 160–166. 2 indexed citations
20.
Thomassen, Mads, Torben A. Kruse, Peter K.A. Jensen, & Anne‐Marie Gerdes. (2006). A Missense Mutation in Exon 13 in BRCA2 , c.7235G>A, Results in Skipping of Exon 13. Genetic Testing. 10(2). 116–120. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy Chaplin Breakdown of academic impact, for papers by Malek Faham Breakdown of academic impact, for papers by Meena Gujrati Breakdown of academic impact, for papers by Stephen Meek Breakdown of academic impact, for papers by Ignacio Varela Breakdown of academic impact, for papers by Alan H. Shih Breakdown of academic impact, for papers by Ellen van Drunen Breakdown of academic impact, for papers by Per Henrik Lindblom Breakdown of academic impact, for papers by Bernd Hinzmann Breakdown of academic impact, for papers by A. Robert MacLeod
Rankless by CCL
2026